Afinitor Disperz
NDC 0078-0626, everolimus, tablet, for suspension, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0626
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203985
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS2 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0626-51 | 00078062651 | 28 BLISTER PACK in 1 CARTON (0078-0626-51) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0626-61) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2150f73a-179b-4afc-b8ce-67c85cc72f04
Use it
Look up 0078-0626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.